Cited by 2,621Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G.J, Miller, N.E·1975·The Lancet

DOI 10.1016/s0140-6736(75)92376-4

Open this paper in CoChat — free account

Abstract

The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(75)92376-4

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456

Show all 59 references

Research works printed but not linked: 13

Miller, 1973, J. Lab. clin. Med., 82, 876
Goodman, 1973, J. Lipid Res., 52, 2646
Insull, 1968, J. Lab. clin. Med., 72, 885
Schreibman, 1973, Clin. Res., 21, 638
P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
Kannel, 1962, Geriatrics, 17, 675
Murphy, 1962, J. Lab. clin. Med., 60, 86
Kudchodkar, 1972, Clin. Res., 20, 944
Jones, 1970, J. Lab. clin. Med., 75, 953
Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123

Sorted by citations

Items 601–700 of 1,001

D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
Valleix, S., Verona, G., Jourde‐Chiche, N., Nédelec, B., Mangione, P. P., Bridoux, F., Mangé, A., Doǧan, A., Goujon, J., Lhomme, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10353 · Cited by 66
High density lipoprotein, apolipoprotein A-1, and coronary artery disease
Srivastava, R., & Srivastava, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007111830472 · Cited by 65
Effects of dietary fats on the fluidity of human high-density lipoprotein: Influence of the overall composition and phospholipid fatty acids
Solà, R., Baudet, M. F., Motta, C., Maillé, M., Boisnier, C., & JACOTOT, B. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90108-a · Cited by 65
Effects of fibrates on serum lipids and atherosclerosis
Sirtori, C. R., & Franceschini, G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90024-1 · Cited by 65
Is paraoxonase related to atherosclerosis
Mackness, M., Arrol, S., Abbott, C. A., & Durrington, P. N. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90038-z · Cited by 65
Effect of exercise training on plasma high-density lipoprotein cholesterol in coronary disease patients
Hartung, G. H., Squires, W. G., & Gotto, A. M. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90664-5 · Cited by 65
High density lipoprotein subfractions and coronary risk factors in normal men.
Robinson, D., Ferns, G., Bevan, E. A., Stocks, J., Williams, P. T., & Galton, D. J. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.341 · Cited by 65
Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: Changes in high-density lipoprotein subfractions and composition
Stubbe, I., Hansson, P., Gustafson, A., & Nilsson‐Ehle, P. (1983) · Metabolism · doi:10.1016/0026-0495(83)90058-6 · Cited by 65
Hypertriglyceridemia: Mechanisms, Clinical Significance, and Treatment
Grundy, S. M. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31433-x · Cited by 65
Hypolipidaemic and antiatherosclerotic effects of oral Gymnema sylvestre R. Br. Leaf extract in albino rats fed on a high fat diet
Bishayee, A., & Chatterjee, M. (1994) · Phytotherapy Research · doi:10.1002/ptr.2650080216 · Cited by 64
Insulin Resistance and Human Disease: A Short History
Reaven, G. M. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.387 · Cited by 65
Micro-RNAs and High-Density Lipoprotein Metabolism
Canfrán‐Duque, A., Lin, C., Goedeke, L., Suárez, Y., & Fernandez-Hernando, C. F. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307028 · Cited by 64
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease
Vuilleumier, N., Reber, G., James, R. W., Burger, D., de Moerloose, P., Dayer, J., & Roux‐Lombard, P. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.08.003 · Cited by 64
Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor
Carson, S. D. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80422-x · Cited by 64
Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population
Taylor, K. G., Carter, T. J., Valente, A. J., Wright, A. D., Smith, J., & Matthews, K. A. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90098-8 · Cited by 64
Metabolic risk factors for atherosclerosis in heart transplant recipients
Kemna, M. S., Valantine, H. A., Hunt, S. A., SCHROEDER, J. S., Chen, Y. I., & Reaven, G. M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90011-6 · Cited by 64
Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical Trials
Corson, S. L. (1990) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349009156503 · Cited by 64
Metabolic basis of primary hypercholesterolemia.
Vega, G. L., Denke, M. A., & Grundy, S. M. (1991) · Circulation · doi:10.1161/01.cir.84.1.118 · Cited by 64
Inverse Relationship in Jamaica between Plasma High-Density Lipoprotein Cholesterol Concentration and Coronary-Disease Risk as Predicted by Multiple Risk-Factor Status
Miller, G. J., Miller, N. E., & Ashcroft, M. T. (1976) · Clinical Science · doi:10.1042/cs0510475 · Cited by 64
Self-citation
Study of the atherogenic dyslipoproteinemia induced by dietary cholesterol in rhesus monekys (Macaca mulatta).
Rudel, L. L., Shah, R., & Greene, D. G. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40651-0 · Cited by 64
Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease The influence of various risk factors
Bihari‐Varga, M., Székely, J., & Gruber, É. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90144-1 · Cited by 64
Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport
Gaidukov, L., Nager, A. R., Xu, S., Penman, M., & Krieger, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229872 · Cited by 63
The −629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men
Eiríksdóttir, G., Bolla, M. K., Thorsson, B., Sigurðsson, G., Humphries, S. E., & Gudnason, V. G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00489-0 · Cited by 63
Insulin Resistance, Hypertension, and Coronary Heart Disease
Reaven, G. M. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.01764.x · Cited by 63
Molecular Dynamics Simulations on Discoidal HDL Particles Suggest a Mechanism for Rotation in the Apo A-I Belt Model
Klon, A. E., Segrest, J. P., & Harvey, S. C. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01143-9 · Cited by 63
Implications of Unique Features of Blood Transport in the Lactating Cow
Puppione, D. L. (1978) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(78)94424-7 · Cited by 63
Plasma lipids as collateral risk factors in coronary artery disease—A study of 371 males with chest pain
Scott, D. W., Gotto, A. M., Cole, J. S., & Gorry, G. A. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90049-8 · Cited by 63
High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease
Devenyi, P., Robinson, G., Kapur, B., & Roncari, D. A. K. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90211-4 · Cited by 63
Cholesteryl ester transfer protein: friend or foe?
Fielding, C. J., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118719 · Cited by 63
Normalization of Triglycerides in Type IV Hyperlipoproteinemia Fails to Correct Low Levels of High-Density-Lipoprotein Cholesterol
Witztum, J. L., Dillingham, M. A., Giese, W. E., Bateman, J., Diekman, C. B., Blaufuss, E. K., Weidman, S. W., & Schonfeld, G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031603 · Cited by 63
Can dysfunctional HDL explain high coronary artery disease risk in South Asians?
Dodani, S., Kaur, R., Reddy, S. N., Reed, G. L., Navab, M., & George, V. T. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.019 · Cited by 64
Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport
Zhang, Z., Yamashita, S., Hirano, K., Nakagawa-Toyama, Y., Matsuyama, A., Nishida, M., Sakai, N., Fukasawa, M., Arai, H., Miyagawa, J., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00490-7 · Cited by 62
Conformation of human serum apolipoprotein A-I(166–185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions
Wang, G., Treleaven, W. D., & Cushley, R. J. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00037-9 · Cited by 62
An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population
Zeng, Q., Dammerman, M., Takada, Y., Matsunaga, A., Breslow, J. L., & Sasaki, J. (1995) · Human Genetics · doi:10.1007/bf00208957 · Cited by 63
Pathophysiology of lipoprotein transport
Brunzell, J. D., Chait, A., & Bierman, E. L. (1978) · Metabolism · doi:10.1016/0026-0495(78)90157-9 · Cited by 62
NALOXONE LOWERS PLASMA-PROLACTIN IN MAN
Rubin, P. C., Swezey, S. E., & Blaschke, T. F. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92248-7 · Cited by 62
Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis
Barth, J. D., Jansen, H., Hugenholtz, P. G., & Birkenhäger, J. C. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90041-2 · Cited by 62
Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients
Rouffy, J., & Jaillard, J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90966-5 · Cited by 62
Τhe Antioxidant Function of HDL in Atherosclerosis
Xepapadaki, E., Zvintzou, E., Kalogeropoulou, C. P., Filou, S., & Kypreos, K. E. (2019) · Angiology · doi:10.1177/0003319719854609 · Cited by 63
High-density lipoprotein subclasses and apolipoprotein A-I
Duriez, P., & Fruchart, J. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00096-0 · Cited by 61
Analysis of high density lipoproteins by a modified gradient gel electrophoresis method.
Li, Z., McNamara, J. R., Ordovás, J. M., & Schaefer, E. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41167-8 · Cited by 61
Fasting Remnant Lipoprotein Cholesterol and Triglyceride Concentrations Are Elevated in Nondiabetic, Insulin-Resistant, Female Volunteers
Abbasi, F., McLaughlin, T., Lamendola, C. A., Yeni-Komshian, H., Tanaka, A., Wang, T., Nakajima, K., & Reaven, G. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6136 · Cited by 61
Secondary type II hyperlipoproteinemia in patients with anorexia nervosa
Mordasini, R., Klose, G., & Greten, H. (1978) · Metabolism · doi:10.1016/0026-0495(78)90125-7 · Cited by 61
Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma
Lagrost, L., Florentin, E., Guyard‐Dangremont, V., Athias, A., Gandjini, H., Lallemant, C., & Gambert, P. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1388 · Cited by 61
Conference on Blood Lipids in Children: Optimal Levels for Early Prevention of Coronary Artery Disease
Berenson, G. S., & Epstein, F. H. (1983) · Preventive Medicine · doi:10.1016/0091-7435(83)90259-1 · Cited by 61
Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
Hegele, R. A., Breslow, J. L., & Cloninger, C. R. (1987) · Genetic Epidemiology · doi:10.1002/gepi.1370040302 · Cited by 60
Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis
Tomás, M., Latorre, G. N., Sentı́, M., & Marrugat, J. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77146-8 · Cited by 60
The physiological aspects of fibrinolysis
Takada, A., Takada, Y., & Urano, T. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90204-6 · Cited by 60
Lipids and lipoproteins in persons with Down's syndrome
Pueschel, S. M., Craig, W. Y., & Haddow, J. E. (1992) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1992.tb00535.x · Cited by 60
Association of Total Cholesterol/High‐Density Lipoprotein Cholesterol Ratio With Proximal Coronary Atherosclerosis Detected by Multislice Computed Tomography
Nair, D., Carrigan, T., Curtin, R. J., Popović, Z., Kuzmiak, S. A., Schoenhagen, P., Flamm, S. D., & Desai, M. Y. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00011.x · Cited by 60
Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity
Matsuzawa, Y., Yamashita, S., KAMEDA, K., Kubo, M., Tarui, S., & Hara, I. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90196-5 · Cited by 60
Lipoprotein substrates for plasma cholesterol esterification
Barter, P. J., Hopkins, G. J., & Gorjatschko, L. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90058-9 · Cited by 60
Effects of Guar Gum and Wheat Bran on Lipid Metabolism of Rats
Chen, W.-J. L., & Anderson, J. W. (1979) · Journal of Nutrition · doi:10.1093/jn/109.6.1028 · Cited by 60
Changes in blood lipids and blood pressure during adolescence.
Orchard, T. J., Rodgers, M., Hedley, A. J., & Mitchell, J. R. A. (1980) · BMJ · doi:10.1136/bmj.280.6231.1563 · Cited by 60
Plasma lipid and lipoprotein concentrations in Chinese males with coronary artery disease, with and without hypertension
Shieh, S.-M., Shen, M., Fuh, M. M.-T., Chen, Y. I., & Reaven, G. M. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90264-4 · Cited by 60
Genome-Wide Linkage Analysis Reveals Evidence of Multiple Regions That Influence Variation in Plasma Lipid and Apolipoprotein Levels Associated With Risk of Coronary Heart Disease
Klos, K. L. E., Kardia, S. L. R., Ferrell, R. E., Turner, S. T., Boerwinkle, E., & Sing, C. F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.971 · Cited by 60
Role of ABCA1 in Cardiovascular Disease
Wang, J., Xiao, Q., Wang, L., Wang, Y., Wang, D. W., & Ding, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12061010 · Cited by 62
Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis
Zhang, H., Bai, Z., Zhu, L., Liang, Y., Fan, X., Li, J., Wen, H., Shi, T., Zhao, Q., & Wang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112665 · Cited by 60
Glucocorticoid inhibition of vascular smooth muscle cell proliferation: influence of homologous extracellular matrix and serum mitogens.
Longenecker, J. P., Kilty, L. A., & Johnson, L. K. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.98.2.534 · Cited by 59
Dietary Fat Clearance in Normal Subjects Is Modulated by Genetic Variation at the Apolipoprotein B Gene Locus
López‐Miranda, J., Ordovás, J. M., Ostos, M., Marín, C., Jansen, S., Salas-Coronas, J., Blanco-Molina, Á., Jiménez-Perepérez, J., Lopez‐Segura, F., & Pérez‐Jiménez, F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1765 · Cited by 59
RELATION OF TRIGLYCERIDE LEVELS TO CORONARY ARTERY DISEASE: THE MILWAUKEE CARDIOVASCULAR DATA REGISTRY
Freedman, D. S., Gruchow, H. W., Anderson, A. J., Rimm, A. A., & Barboriak, J. J. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114906 · Cited by 59
Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment
Luoma, P. V., Sotaniemi, E. A., Pelkonen, R. O., & Myllylä, V. V. (1980) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518009093020 · Cited by 59
Effect of Alcohol Intake on Human Apolipoprotein A-I—Containing Lipoprotein Subfractions
Puchois, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00040031638010 · Cited by 59
Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity
Yu, M., Romer, K. A., Nieland, T. J. F., Xu, S., Saenz-Vash, V., Penman, M., Yesilaltay, A., Carr, S. A., & Krieger, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109078108 · Cited by 58
Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function
Filou, S., Lhomme, M., Karavia, E. A., Kalogeropoulou, C. P., Theodoropoulos, V., Zvintzou, E., Sakellaropoulos, G. C., Πετροπούλου, Π.-Ι., Constantinou, C., Kontush, A., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00389 · Cited by 60
Fish oil supplementation in patients with stable claudication
Gans, R. O. B., Bilo, H. J. G., Weersink, E. G. L., Rauwerda, H., Fonk, T., Popp‐Snijders, C., & Donker, A. J. M. (1990) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)81012-8 · Cited by 58
Studies of esterified cholesterol in sub-fractions of plasma high density lipoproteins
Barter, P. J., Ha, Y. C., & Calvert, G. D. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90113-1 · Cited by 58
Alterations in lipid and protein profiles of plasma lipoproteins in middle-aged men consequent to an aerobic exercise program
Baker, T. T., Allen, D., Lei, K. Y., & Willcox, K. K. (1986) · Metabolism · doi:10.1016/0026-0495(86)90040-5 · Cited by 58
Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses.
Williams, P. T., VRANIZAN, K. M., Austin, M. A., & Krauss, R. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.11.1654 · Cited by 58
HDL-cholesterol and other plasma lipid and lipoprotein concentrations in middle-aged male and female tennis players
Vodak, P. A., Wood, P. D., Haskell, W. L., & Williams, P. T. (1980) · Metabolism · doi:10.1016/0026-0495(80)90197-3 · Cited by 58
Characterization of high density lipoproteins in patients heterozygous for Tangier disease.
Assmann, G., Simantke, O., Schaefer, H.-G., & Smootz, E. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108853 · Cited by 58
The Clinical Significance of the Plasma High Density Lipoproteins
Eder, H. A., & Gidez, L. I. (1982) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31428-6 · Cited by 58
Serum total lipids, lipoproteins cholesterol, apoproteins A and B in cardiovascular disease
Vergani, C., Trovato, G. M., & Dioguardi, N. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90066-9 · Cited by 58
Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance
Kalopissis, A. D., Pastier, D., & Chambaz, J. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00008 · Cited by 57
Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans
Kim, J. J., Yoon, J., Lee, Y., Park, B., & Jung, D. (2021) · Nutrients · doi:10.3390/nu13093231 · Cited by 58
Lipoprotein heterogeneity in end-stage renal disease
Joven, J., Vilella, E., Ahmad, S., Cheung, M. C., & Brunzell, J. D. (1993) · Kidney International · doi:10.1038/ki.1993.60 · Cited by 57
Assessment of Between-Instrument Variations in a HPLC Method for Serum Lipoproteins and Its Traceability to Reference Methods for Total Cholesterol and HDL-Cholesterol
Usui, S., Nakamura, M., Jitsukata, K., Nara, M., Hosaki, S., & Okazaki, M. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.1.63 · Cited by 57
High density lipoprotein cholesterol, total cholesterol and triglycerides in serum after a single exposure to prolonged heavy exercise
Enger, S. C., Strømme, S. B., & Refsum, H. E. (1980) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518009092653 · Cited by 57
Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease
Richards, E. G., Grundy, S. M., & Cooper, K. H. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90181-1 · Cited by 57
Cholesterol metabolism in cancer cells in monolayer culture
Gal, D., MacDonald, P. C., Porter, J. C., & Simpson, E. R. (1982) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(82)90079-0 · Cited by 57
Fenofibrate therapy of hyperlipoproteinaemia a dose—response study and a comparison with clofibrate
Rössner, S., & Orö, L. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90043-5 · Cited by 57
Flux of plasma lipoproteins into human arterial intima Comparison between grossly normal and atheromatous intima
Nicoll, A., Duffield, R., & Lewis, B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90073-3 · Cited by 57
The lipoproteins: predictors, protectors, and pathogens.
Lewis, B. (1983) · BMJ · doi:10.1136/bmj.287.6400.1161 · Cited by 57
Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children
Demircioğlu, S., Soylu, A., & Dırık, E. (2000) · Pediatric Neurology · doi:10.1016/s0887-8994(00)00175-2 · Cited by 56
Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3.
Demacker, P. N. M., van Sommeren-Zondag, D. F., Stalenhoef, A. F. H., Stuyt, P. M. J., & Laar, A. V. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.4.656 · Cited by 56
Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles.
Lagrost, L., Dengremont, C., Athias, A., Geitere, C. D., Fruchart, J., Lallemant, C., Gambert, P., & Castro, G. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13004 · Cited by 56
THE RELATIONSHIP OF PHYSICAL ACTIVITY TO CORONARY HEART DISEASE AND LIFE EXPECTANCY
Leon, A. S., & BLACKBURN, H. W. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb38230.x · Cited by 56
Effect of high-carbohydrate-low-fat diets on plasma glucose, insulin and lipid responses in hypertriglyceridemic humans
Liu, G. C., Coulston, A. M., & Reaven, G. M. (1983) · Metabolism · doi:10.1016/0026-0495(83)90103-8 · Cited by 56
The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins
Barter, P. J., Chang, L., Newnham, H. H., Rye, K., & Rajaram, O. V. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90206-d · Cited by 56
The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis
Steinberg, D. H. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00821.x · Cited by 56
Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema
Birjmohun, R. S., Hovingh, G. K., Stroes, E. S. G., Hofstra, J. J., Dallinga‐Thie, G. M., Meijers, J. C. M., Kastelein, J. J. P., & Levi, M. M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.021 · Cited by 55
Plasma lipids in premenopausal women with mammographic dysplasia
Boyd, N. F., McGuire, V. M., Fishell, E., Kuriov, V., Lockwood, G., & Tritchler, D. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.160 · Cited by 55
Estrogen Increases Apolipoprotein (Apo) A-I Secretion in Hep G2 Cells by Modulating Transcription of the Apo A-I Gene Promoter
Lamon‐Fava, S., Ordovás, J. M., & Schaefer, E. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2960 · Cited by 55
Structure and expression of dog apolipoprotein A-I, E, and C-I mRNAs: implications for the evolution and functional constraints of apolipoprotein structure.
Luo, C. C., Li, W. H., & Chan, L. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38213-4 · Cited by 41
Conformation of Two Peptides Corresponding to Human Apolipoprotein C-I Residues 7-24 and 35-53 in the Presence of Sodium Dodecyl Sulfate by CD and NMR Spectroscopy
Rozek, A., Buchko, G. W., & Cushley, R. J. (1995) · Biochemistry · doi:10.1021/bi00022a013 · Cited by 55
Interaction of dietary sucrose and fiber on serum lipids in healthy young men fed high carbohydrate diets
Albrink, M. J., & Ullrich, I. H. (1986) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/43.3.419 · Cited by 55
Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug
Carlson, L. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00233.x · Cited by 56
Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
Sakai, N., Yamashita, S., Hirano, K., Menju, M., Arai, T., Kobayashi, K., Ishigami, M., Yoshida, Y., Hoshino, T., Nakajima, N., et al. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05477-z · Cited by 55
Serum high density lipoprotein cholesterol in diabetes mellitus: An analysis of factors which influence its concentration
Durrington, P. N. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90130-8 · Cited by 55
A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease
Zhao, Q., Wang, J., Miao, Z., Zhang, N. R., Hennessy, S., Small, D. S., & Rader, D. J. (2021) · eLife · doi:10.7554/elife.58361 · Cited by 57

Authors: Miller, G. J., & Miller, N. E.
Affiliations: University Hospital Llandough (GB)
Edinburgh Royal Infirmary (GB)
ORCID: Miller, G.J
Venue: The Lancet
Publisher: Elsevier BV
Published: 1975-01
Volume: 305
Issue: 7897
Pages: 16-19
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(75)92376-4
OpenAlex: W1994967652
Cited by: 2,621
References: 59
Citations by year: 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
FWCI: 157.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
MeSH terms: Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks